Valuation Appili Therapeutics Inc.

Stocks

Market Closed - Toronto S.E. 12:26:50 2026-09-29 EDT			5-day change	1st Jan Change
0.0100 ^CAD	-.--%		-.--%	-60.00%

08-14	Appili Therapeutics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-04	Appili Therapeutics Inc. Receives Notice of Termination for Convenience from National Institute of Allergy and Infectious Diseases on Contract for VXV-01 Program	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	69.68	8.552	4.851	4.244	4.244	1.985
Change	-	-87.73%	-43.28%	-12.5%	0%	-53.22%
Enterprise Value (EV) ¹	54.59	6.866	10.05	12.33	15.31	14.88
Change	-	-87.42%	46.38%	22.73%	24.13%	-2.8%
P/E	-4.59x	-0.32x	-0.49x	-1.12x	-1.62x	-0.44x
PBR	5.46x	-2.61x	-0.66x	-0.39x	-0.32x	-0.11x
PEG	-	-0x	0x	0x	0.1x	-0x
Capitalization / Revenue	-	6,149,444x	14,515,194x	5,129,657x	42,255,946x	8,131,293x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-3.49x	-0.28x	-1.27x	-1.53x	-1.52x	-2.28x
EV / EBIT	-3.49x	-0.28x	-1.27x	-1.53x	-1.52x	-2.28x
EV / FCF	-7.79x	-0.59x	-1.36x	-2.36x	-1.79x	-4.97x
FCF Yield	-12.8%	-170%	-73.3%	-42.3%	-55.7%	-20.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.2421	-0.3764	-0.0813	-0.0312	-0.0216	-0.0343
Distribution rate	-	-	-	-	-	-
Net sales	-	1.391	0.3342	0.8274	0.1004	0.2442
EBITDA ¹	-15.65	-24.61	-7.908	-8.037	-10.07	-6.517
EBIT ¹	-15.66	-24.62	-7.914	-8.05	-10.09	-6.525
Net income ¹	-14.33	-25.12	-9.243	-3.781	-2.625	-4.241
Net Debt ¹	-15.09	-1.686	5.199	8.09	11.07	12.9
Reference price ²	1.1100	0.1200	0.0400	0.0350	0.0350	0.0150
Nbr of stocks (in thousands)	62,776	71,266	121,266	121,266	121,266	132,366
Announcement Date	6/24/21	6/29/22	6/23/23	6/26/24	6/26/25	6/27/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APPILI THERAPEUTICS INC.	-	-	-	-	929K
WUXI APPTEC CO., LTD.	21.73x	7.77x	15.61x	1.37%	74.41B
ARGENX SE	30.79x	8.87x	27.62x	0.04%	59.26B
LONZA GROUP AG	32.79x	5.89x	17.64x	0.99%	47.14B
IQVIA HOLDINGS INC.	33.58x	3.26x	14.07x	-.--%	42.91B
REVOLUTION MEDICINES, INC.	-21.23x	229.92x	-22.88x	-.--%	44.13B
BEONE MEDICINES AG	46.86x	5.42x	29.73x	-.--%	40.79B
CELLTRION, INC.	27.79x	7.97x	20.59x	0.41%	30.77B
WUXI BIOLOGICS (CAYMAN) INC.	33.94x	7.26x	18.84x	-.--%	29.31B
INSMED INCORPORATED	-66.62x	12.77x	-65.09x	-.--%	23.71B
Average	15.51x	32.13x	6.24x	0.31%	39.24B
Weighted average by Cap.	19.55x	32.23x	10.39x	0.42%